Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hebei Weierli Animal Healthcare Technology Group is a prominent Chinese veterinary pharmaceutical enterprise headquartered in Shijiazhuang, Hebei Province. Established in 2001, the group integrates research and development, large-scale manufacturing, and global sales of animal health products. Their extensive portfolio includes chemical drugs, traditional Chinese veterinary medicines, feed additives, and disinfectants tailored for poultry, livestock, and companion animals. The company operates multiple GMP-certified production lines and is recognized as a leading high-tech enterprise in the Chinese animal pharmacy industry. Weierli Group maintains a significant international presence, exporting its veterinary solutions to numerous countries across Southeast Asia, Africa, and the Middle East.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hebei Weierli Animal Healthcare Technology Group.